Genotyping mice at 55% EBITDA - Acquisitions Anonymous 272
Genotyping mice at 55% EBITDA - Acquisitions Anonymous 272
In this episode of Acquisitions Anonymous, Michael and Heather discuss an investment opportunity in a genomic testing , specializing in...
Let us know if you enjoyed this episodeIn this episode of Acquisitions Anonymous, Michael and Heather discuss an investment opportunity in a genomic testing , specializing in DNA sequencing and genotyping for mice. Despite their initial unfamiliarity with the technical details, they recognize the company's significant role in pharmaceutical research. They are impressed by its financial performance, noting substantial growth in revenue and EBITDA, along with high margins. The conversation also...
Episode Transcript
More Episodes
Would You Risk Millions on This IV Clinic Franchise?
In this episode, the hosts dissect a $12M IV therapy franchise deal in oil-rich Midland, Texas—and uncover a mix of sketchy math, questionable branding, and a saturated niche market.
This Golf Club Could Make $600K a Year… Or Bankrupt You
In this episode, the hosts break down a $4.6M rural golf course deal with sketchy financials, a possible connection to Blackwater, and more red flags than a PGA tournament.
This E-Commerce Dental Business Might Be Dead Thanks to Tariffs
In this episode, the hosts dissect a high-margin dental supply e-commerce carve-out deal and uncover how a recent legislative change may have obliterated its business model.